Back to Search
Start Over
Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
- Source :
-
Brain research. Molecular brain research [Brain Res Mol Brain Res] 2002 Sep 30; Vol. 105 (1-2), pp. 38-46. - Publication Year :
- 2002
-
Abstract
- The recently discovered endogenous peptide orphanin FQ/nociceptin (OFQ/N) activates the opioid receptor-like 1 (ORL1) receptor and produces diverse effects on pain perception. In addition to producing spinal analgesia, OFQ/N also exhibits an 'anti-opioid activity' against functional (supraspinal analgesia) and behavioral (conditioned place preference and withdrawal) properties of morphine. One manifestation of the behavioral changes resulting from chronic use of morphine is the upregulation of tyrosine hydroxylase (TH, the rate-limiting enzyme in catecholamine biosynthesis), which contributes to the dramatic increases in catecholamine release in the target regions of the locus coeruleus (LC) and the ventral tegmental area (VTA). The present study sought to determine the molecular mechanism(s) by which OFQ/N modulates the chronic actions of morphine by utilizing human neuroblastoma cell lines [BE(2)-C and SH-SY5Y] that endogenously express TH, and mu and ORL1 receptors. Activation of mu or ORL1 receptors in these cells in turn activates extracellular signal-regulated protein kinases (ERKs), ERK1 and ERK2. Chronic activation of mu, but not ORL1, receptors upregulated TH levels in these cells as previously reported in rat brain. Morphine-induced TH upregulation was blocked upon inclusion of a MEK-1 (mitogen-activated protein kinase kinase-1) inhibitor (PD98059), confirming the role for ERKs in this adaptive response to morphine. Inclusion of OFQ/N during chronic morphine exposure also blocked morphine-induced TH upregulation. Furthermore, chronic OFQ/N exposure increased levels of the TH gene repressor, Oct-2, irrespective of the presence or absence of morphine. This report suggests a potential role for Oct-2 in mediating the anti-opioid actions of OFQ/N against the behavioral manifestations resulting from chronic use of morphine.<br /> (Copyright 2002 Elsevier Science B.V.)
- Subjects :
- Brain physiopathology
Catecholamines metabolism
Chronic Disease
DNA-Binding Proteins drug effects
DNA-Binding Proteins metabolism
Dose-Response Relationship, Drug
Humans
Mitogen-Activated Protein Kinases drug effects
Mitogen-Activated Protein Kinases metabolism
Morphine metabolism
Morphine Dependence physiopathology
Neurons drug effects
Neurons enzymology
Octamer Transcription Factor-2
Opioid Peptides metabolism
Receptors, Opioid drug effects
Receptors, Opioid metabolism
Receptors, Opioid, mu drug effects
Receptors, Opioid, mu metabolism
Transcription Factors drug effects
Transcription Factors metabolism
Tumor Cells, Cultured
Tyrosine 3-Monooxygenase metabolism
Up-Regulation physiology
Nociceptin Receptor
Nociceptin
Brain drug effects
Brain enzymology
Morphine antagonists & inhibitors
Morphine Dependence enzymology
Opioid Peptides pharmacology
Tyrosine 3-Monooxygenase antagonists & inhibitors
Up-Regulation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0169-328X
- Volume :
- 105
- Issue :
- 1-2
- Database :
- MEDLINE
- Journal :
- Brain research. Molecular brain research
- Publication Type :
- Academic Journal
- Accession number :
- 12399106
- Full Text :
- https://doi.org/10.1016/s0169-328x(02)00390-x